Goulburn Valley Health
Shepparton, Victoria, Australia
Hospital in Victoria
2/2-48 Graham St, Shepparton VIC 3630
About Goulburn Valley Health
Goulburn Valley Health, formerly called the Goulburn Valley Base Hospital, is based in the regional city of Shepparton, 2 hours drive north of Melbourne, and caters for the 160,000 people in its region.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Melbourne
2
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
1
Calithera Biosciences, Inc
1
Eli Lilly and Company
1
HUYABIO International, LLC.
1
Hoffmann-La Roche
1
Loxo Oncology, Inc.
1
Molecular Templates, Inc.
1
National Cancer Centre, Singapore
1
Neuroscience Trials Australia
1
Peter MacCallum Cancer Centre, Australia
1
Clinical Trials at Goulburn Valley Health
During the past decade, Goulburn Valley Health conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
2008-12-01
2026-06-01
Active, not recruiting
1,587
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
2014-03-01
2024-12-01
Active, not recruiting
1,125
A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
2016-06-01
2021-05-12
Completed
1,253
Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
2017-12-06
2020-02-01
Completed
300
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
2018-04-24
2021-07-16
Completed
444
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Available
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Goulburn Valley Health" #1 sponsor was "University of Melbourne" with 2 trials, followed by "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials
sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "HUYABIO International, LLC."
with 1 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Goulburn Valley Health"
#1 collaborator was "Middlemore Clinical Trials" with 2 trials as a collaborator, "The Peter Doherty Institute for Infection and Immunity" with 2 trials as a collaborator, "The University of Queensland" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 31 trials.
Clinical Trials Conditions at Goulburn Valley Health
According to Clinical.Site data, the most researched conditions in "Goulburn Valley Health" are
"Colorectal Cancer" (2 trials), "Advanced Renal Cell Carcinoma" (1 trials), "Alzheimer's Disease" (1 trials), "Arterial Thrombosis" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Goulburn Valley Health" in a lesser frequency.
Clinical Trials Intervention Types at Goulburn Valley Health
Most popular intervention types in "Goulburn Valley Health" are "Drug" (19 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (1 trials), "Acetylsalicylic acid" (1 trials), "Bevacizumab" (1 trials) and "CB-839" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Goulburn Valley Health
The vast majority of trials in "Goulburn Valley Health" are
16 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Goulburn Valley Health
Currently, there are NaN active trials in "Goulburn Valley Health".
undefined are not yet recruiting,
9 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Goulburn Valley Health,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Goulburn Valley Health, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".